Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
COG7-CDG is a congenital disorder of glycosylation characterized by dysmorphism, skeletal dysplasia, hypotonia, hepatosplenomegaly, jaundice, cardiac insufficiency, recurrent infections and epilepsy. To date, it has been described in two infants, both of whom died within the first three months of life. The syndrome is caused by a mutation in the gene encoding COG-7 (chromosome 16), a subunit of the oligomeric Golgi complex.
Features include always present findings: Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Narrow mouth, Low muscle tone (hypotonia), and Generalized hypotonia and others; and very common findings: Seizure. 56 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 6 | Decreased liver function, Gastroesophageal reflux, Jaundice |
COG7 encodes component of oligomeric golgi complex 7 (770 aa). Required for normal Golgi function Highest expression in Pituitary (44.3 TPM) and Cervix Endocervix (32.6 TPM).
COG7-congenital disorder of glycosylation is caused by mutations in the COG7 gene on chromosome 16.
COG7 is classified as a druggable target with score 0.0.
Genetic testing for COG7 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 22 always present features, 1 very common feature, 13 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 8:50 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about COG7-congenital disorder of glycosylation
Muscles |
5 |
Low muscle tone (hypotonia), Generalized hypotonia, Skeletal muscle atrophy |
Growth and development | 4 | Short stature, Failure to thrive, Intrauterine growth retardation |
Brain and nerves | 4 | Seizure, Hyporeflexia, Profound global developmental delay |
Lab test results | 3 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated circulating aspartate aminotransferase concentration, Elevated circulating alanine aminotransferase concentration |
Heart and blood vessels | 3 | Perimembranous ventricular septal defect, Secundum atrial septal defect, Congestive heart failure |
Head and neck | 2 | Progressive microcephaly, Primary microcephaly |
Blood and immune system | 2 | Recurrent infections, Enlarged spleen (splenomegaly) |
Bones and joints | 1 | Skeletal muscle atrophy |
Arms and legs | 1 | Overlapping fingers |
Skin | 1 | Excessive wrinkled skin |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Pregnancy and birth | 1 | Neonatal asphyxia |
Lungs and breathing | 1 | Difficulty breathing (respiratory insufficiency) |